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Introduction 
Electro-convulsive therapy (ECT) is 
one of the important treatment modality 
for psychiatric patients, particularly in de-
veloping countries like India. The introduc-
tion of curare and subsequently succinyl-
choline chloride (Holmerg and Thesleff 
1952) as an important adjunct in the admi-
nistration of ECT, was a major advance in 
reducing the morbidity associated with 
ECT. The relative safety of succinylchol-
ine, a depolarising neuromuscular blocking 
agent, in ECT, has been extensively investi-
gated (Holmerg and Thesleff 1952, Pitts et 
al 1968). Side effects of succinylcholine 
(include bronchial secretion, bradycardia, 
bronchospasm, muscle pain and hyperka-
laemia (Wylie and Churchill Davidson 
1966). One rare serious complication of 
succinylcholine administration is pro-
longed apnoea due most often to an in-
creased duration of action. This increased 
duration of action may result from de-
creased metabolism of succinylcholine as 
seen in genetic pseudocholinesterase defi-
ciency syndrome (Lehmaun and Liddell 
1969), exposure to or treatment with anti-
cholinesterase agents (Pantuck 1966) or as a 
result of additive effects caused by other 
drugs having neuromuscu lar blocking side 
effects (Pittinger et al 1970). Shortly after 
clinical introduction of succinylcholine, re-
ports appeared describing prolonged ap-
noea immediately following the drug's ad-
ministration during surgical procedures 
(Argent et al 1955) or after ECT (Hurley 
and Munro 1952). 
Three case histories, where prolonged 
apnoea was observed during ECT follow-
ing administration of succinylcholine chlo-
ride are tabulated below: 
Discussion 
The postseizure apnoea was of normal 
duration during second ECT (given after 
seven days) in all the three cases. Hence the 
cause for prolonged apnoea with succinyl-
choline chloride like genetic pseudocholi-
nesterase deficiency, liver disease or malnu-
trition in these cases are ruled out. 
All the three cases had consumed or-
ganophosphorous insecticides. Organo-
phosphorous compounds are cholinesterase 
Table 
Summary of Findings 
Age/Sex/ 
Diagnosis 




Dose of Duration Next ECT Dose of Duration 
Succinylcholine of given Succinylcholine of 
Apnoea after Apnoea 
1) 22/M/End.Dep. 3 days 
2) 19/F/Schiz. 3 days 
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inhibitors. These compounds combine with 
SH radicle of the enzyme and act by causing 
irreversible inhibition of cholinesterases 
(Scott 1966). This causes clinically important 
reduction in cholinesterase activity to such a 
degree that prolonged apnoea occurs after 
succinylcholine administration. 
Organophosphate anticholinesterase 
are rarely used clinically but are often used 
in insecticides and as weapon for chemical 
war (nerve gases). However in treatment of 
glaucoma topically administered organo-
phosphate anticholinesterase may be pres-
cribed from where sufficient absorption 
may take place leading to significant reduc-
tion in cholinesterase activity. Chessent et 
al (1974) and Packman et al (1978) have 
described a case each, where there was pro-
longed apnoea following succinylcholine 
administration during ECT, the cause be-
ing topically administered organophos-
phate compound for glaucoma. 
These reports stress the importance of 
using a non-depolarizing muscle relaxant or 
waiting until serum cholinesterase activity 
returns to normal in such patients. In all the 
three cases the apnoea after succinylcholine 
was of normal duration after seven days. 
Hence if one has to administer succinylchol-
ine for any reason it should be administered 
after seven days by which time serum choli-
nesterase activity would return to normal 
References 
ARGENT, D. E., DIMICK, D. P. & HOBBING-
ER, F. (1955), Prolonged apnoea after suxa-
methonium in man. British Journal of Anaes-
thesia, 24, 24-30. 
CHESSEN, D. H„ GEHA, D. C. & SALZMEN, 
C. (1974), ECT, glaucoma and prolonged ap-
noea. Diseases of Nervous System, 35,152-155. 
HOLMERG, G. & THESLEFF, S. (1952), Succi-
nylcholine iodide as a muscular relaxant in 
electro-shock Therapy. American Journal of 
Psychiatry, 108, 842-846. 
HURLEY, M. J. & MUNRO, A. B. (1952), Pro-
longed respiratory paralysis after succinyl-
choline. British Medical Journal, 1, 1027-
1029. 
LEHMAUN, H. & LIDDELL, J. (1969), Genet-
ic Variants and their recognition. British Jour-
nal of Anaesthesia, 41, 235-240. 
PACKMAN, P. M., MEYER, D. A. & VARDUN 
R. M. (1978), Hazards of succinylcholine ad-
ministration during electro-therapy. Archives 
of General Psychiatry, 35, 1137-1141. 
PANTUCK, E. J. (1966), Ecothiophate iodide 
eye drops and prolonged response to sexa-
methonium - a case report. British Journal of 
Anaesthesis, 38, 406-408. 
PITTINGER, C. B., ERYASA, Y. & ADAM-
SON, R. (1970), Antibiotics - induced para-
lysis. Anaesthesia Analogue, 49, 487-493. 
PITTS, F. M. Jr., WOODRUFF, R. A., CRAIG, 
A. G. (1968), The drug modification of ECT 
II Succinylcholine dosage. Archives of Gen-
eral Psychiatry, 19, 595-605. 
SCOTT, R. B. (1966), Price's Textbook of the 
Practice of Medicine 10th edition, Oxford 
University Press, London. 
WYLIE, W. D. & CHURCHILL-DAVIDSON, 
H. C. (1966), A practice of Anaesthesia, 2nd 
Edition, LJoyd-Luke (Medical Books), 
London. 